If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSLT.L Regulatory News (CSLT)

  • There is currently no data for CSLT

Rule 8.3- Cosalt PLC

10 Aug 2009 16:03

RNS Number : 1896X
David Ross
10 August 2009
Β 

ο»Ώ

Β  FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MOREΒ 

(Rule 8.3 ofΒ theΒ TakeoverΒ Code)

1. KEY INFORMATION

Name of person dealingΒ Β (Note 1)

David Ross

Company dealt in

Cosalt

Class of relevant security to which the dealings being disclosed relateΒ (Note 2)

Ordinary 1p

Date of dealing

05/08/09

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) InterestsΒ and short positionsΒ (following dealing) in the class of relevant security dealt inΒ (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

3,989,296 15.1%

(2) DerivativesΒ (other than options)

(3)Β OptionsΒ and agreements to purchase/sell

Total

3,989,296 15.1%

(b) InterestsΒ and short positionsΒ in relevant securities of the company, other than theΒ classΒ dealt inΒ (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

(2) DerivativesΒ (other than options)

(3)Β OptionsΒ and agreements to purchase/sell

Total

(c) Rights to subscribeΒ (Note 3)

Class of relevant security:

Details

Ordinary shares

Fitel Nominees LimitedΒ has agreed to subscribe forΒ 22,200,000Β new ordinary shares in the proposed firm placing by Cosalt. Should the Firm placing proceed as proposed thenΒ Fitel Nominees LimitedΒ Β would as a result of the firm placing be interested inΒ 26,189,296Β new ordinary shares representingΒ 6.47%Β ofΒ 404,403,397 being the total new ordinary shares

3. DEALINGSΒ (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unitΒ (Note 5)

(b) Derivatives transactions (other than options)

Product name,Β 

e.g. CFD

Long/shortΒ (NoteΒ 6)

Number of securitiesΒ (Note 7)

Price per unitΒ (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Β callΒ option

Writing, selling, purchasing, varying etc.

Number of securitiesΒ to which the option relatesΒ (Note 7)

Exercise

priceΒ 

Type,Β e.g. American, European etc.

ExpiryΒ 

date

Option money

paid/receivedΒ per unitΒ (Note 5)Β 

(ii) Exercising

Product name,Β e.g.Β call option

Number of securitiesΒ 

Exercise priceΒ per unitΒ (Note 5)

(d) Other dealings (including new securities)Β (Note 4)

Nature of transactionΒ (Note 8)

Details

PriceΒ per unitΒ (if applicable)Β (Note 5)

Participation in Firm placing

See section 2.c above

5p

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form orΒ relating to the voting rights orΒ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?Β (Note 9) YES/NO

Date of disclosure

10/08/09

Contact name

N Lamb

Telephone number

02072201673

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM,Β state natureΒ of connectionΒ (NoteΒ 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETPMMATMMMBBML
Date   Source Headline
10th Apr 20073:10 pmRNSTotal Voting Rights
10th Apr 20072:29 pmRNSDirector/PDMR Shareholding
2nd Apr 200712:42 pmRNSIssue of Equity
2nd Apr 200712:16 pmRNSDirector Declaration
2nd Apr 20077:03 amRNSIssue of Equity
27th Mar 20079:18 amRNSResult of AGM
26th Mar 20077:03 amRNSBoard Changes
22nd Mar 20072:37 pmRNSAnnual Information Update
8th Mar 200711:56 amRNSDirector/PDMR Shareholding
1st Mar 20071:56 pmRNSDirector/PDMR Shareholding
1st Mar 20071:48 pmRNSTotal Voting Rights
28th Feb 20078:38 amRNSDirector/PDMR Shareholding
27th Feb 20077:00 amRNSBlock Listing of Shares
23rd Feb 20071:37 pmRNSDirector/PDMR Shareholding
20th Feb 20077:00 amRNSFinal Results
22nd Jan 20077:01 amRNSNotice of Results
16th Jan 20077:01 amRNSRetention of Banner
28th Dec 20061:56 pmRNSCompletion of Acquisition
21st Dec 20064:26 pmRNSTotal Voting Rights
15th Dec 20063:54 pmRNSAcquisition and share placing
12th Dec 20064:26 pmRNSHolding(s) in Company
12th Dec 20064:24 pmRNSDirector/PDMR Shareholding
8th Nov 200611:59 amRNSDirector/PDMR Shareholding
6th Nov 20061:54 pmRNSHolding(s) in Company
21st Sep 20069:27 amRNSHolding(s) in Company
11th Sep 20061:05 pmRNSHolding(s) in Company
6th Sep 20067:01 amRNSTrading Statement
4th Aug 20063:51 pmRNSDirector/PDMR Shareholding
1st Aug 20064:57 pmRNSHolding(s) in Company
1st Aug 20064:53 pmRNSHolding(s) in Company
1st Aug 20061:33 pmRNSDirector/PDMR Shareholding
1st Aug 200611:01 amRNSDirector/PDMR Shareholding
1st Aug 20067:01 amRNSNew Chief Executive
19th Jul 20064:39 pmRNSHolding(s) in Company
5th Jul 200612:42 pmRNSHolding(s) in Company
27th Jun 20067:01 amRNSInterim Results
24th May 200612:51 pmRNSDisposal of Banner
10th Apr 200612:58 pmRNSDirector/PDMR Shareholding
10th Apr 200612:54 pmRNSDirector/PDMR Shareholding
10th Mar 20065:45 pmRNSHolding(s) in Company
31st Jan 20067:00 amRNSFinal Results
25th Oct 20053:28 pmRNSHolding(s) in Company
25th Oct 20057:26 amRNSDirector/PDMR Shareholding
19th Oct 20052:16 pmRNSDirector/PDMR Shareholding
27th Sep 20057:00 amRNSTrading Update
2nd Aug 200511:01 amRNSDirector/PDMR Shareholding
2nd Aug 20057:00 amRNSAppointment of Chairman
28th Jun 20057:00 amRNSInterim Results
12th Apr 200512:01 pmRNSHolding(s) in Company
12th Apr 20057:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.